2 terminated. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
| Phase 3 | 1 | Terminated 1 |
Follow VAP-cyclo protocol: new trials by email Literature Review of VAP-cyclo protocol trials Research Report on VAP-cyclo protocol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Ibrutinib & Obinutuzumab With/Without CHOP for Richter's Transformation or Richter's Syndrome Patients Obinutuzumab, Ibrutinib, CHOP - Richter Syndrome | Phase 2 | Terminated | Northwell Health | 3 | 2017-06-19 | 2023-06-01 |
| Combination Chemotherapy With or Without Etoposide in Treating Older Patients With Non-Hodgkin's Lymphoma CHOP regimen, EPOCH regimen, cyclophosphamide - Lymphoma | Phase 2 / Phase 3 | Terminated | European Organisation for Research and Treatment of Cancer - EORTC | 3 | 2003-03-01 | 2012-09-24 |
Leukemia (1) · Lymphoma (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, T-Cell, Cutaneous (1) · Mycosis Fungoides (1) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1) · Sezary Syndrome (1)
European Organisation for Research and Treatment of Cancer - EORTC (1) · Northwell Health (1)
Belgium (1) · United States (1)
Jacqueline Barrientos, MD (1) · Pierre Soubeyran, MD, PhD (1)